Top Medical News

Patient Education Key in Managing Immune-Related Adverse Events

October 14th 2021

An expert on immune toxicity management discusses dermatologic, gastrointestinal, hepatic, and endocrine irAEs and how nurses can help educate their patients to monitor these symptoms.

Advanced Practice Fellowships Prepare Recent Graduates for Success in Oncology

October 14th 2021

The Oncology Nurse Practitioner Fellowship at Sylvester Comprehensive Cancer Center exposes fellows to the gamut of oncology care and teaches the skills they need to succeed.

FDA Approves Pembrolizumab Combination to Treat First-Line Cervical Cancer

October 13th 2021

Pembrolizumab is approved both in combination with chemotherapy, with or without bevacizumab, and as a single agent for the treatment of patients with recurrent or metastatic cervical cancer.

FDA Approves Abemaciclib for HR+, HER2– High-Risk Early Breast Cancer

October 13th 2021

Abemaciclib is the first and only FDA approved CDK4/6 inhibitor to treat HR-positive, HER2-negative high-risk early breast cancer.

Autologous HSCT Continues to Show Sustained Benefit in MCL, But Targeted Therapies May Challenge its Role as Standard Frontline Treatment

October 12th 2021

Autologous hematopoietic stem-cell transplantation, the standard frontline treatment in treating patients with mantel cell lymphoma, demonstrated superior long-term efficacy compared with interferon alfa in a recent trial.


Most Recent